Clinical Trials Logo
  1. Home
  2. Alzheimer Disease, Late Onset
  3. NCT01773915

New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study

Alzheimer Disease, Late Onset Clinical Trial

Official title:
New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study

Clinical Trial Summary

Alzheimer's disease (AD) is the most common neurodegenerative disorder afflicting the elderly. Currently, some biochemical tests performed on Cerebrospinal Fluid (CSF) samples have demonstrated to discriminate to some extend between AD and non-AD individuals based on the levels of tau, phospho-tau or Aβ42. We aim to investigate newly identified proteins whose levels increase during the Braak Stages of AD that are accessible in other body fluids such as blood, urine or saliva. The detection of these proteins would allow performing simple tests in case its levels were confirmed to be associated with the AD pathology.

Clinical Trial Description

We do not desire to provide a more extensive description ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01773915
Study type Observational
Source Universitaire Ziekenhuizen Leuven
Contact Jos Tournoy
Phone +3216342640
Email jos.tournoy@uzleuven.be
Status Recruiting
Phase N/A
Start date December 2012
Completion date June 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT05407272 - Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care N/A
Completed NCT02958930 - Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease N/A
Completed NCT04449926 - BCG and Plasma Amyloid in Non-Demented Adults Phase 2
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Not yet recruiting NCT05183516 - Tdap and Biomarkers of Alzheimer's Disease Phase 1/Phase 2
Recruiting NCT04263194 - Network-based rTMS in Alzheimer's Disease N/A
Recruiting NCT04100889 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Completed NCT02187276 - The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia N/A
Recruiting NCT04680013 - Genetic Studies in Familial Dementia
Recruiting NCT04270474 - Reducing Risk of Dementia Through Deprescribing N/A
Not yet recruiting NCT06448403 - Multimodal Assesment of Alzheimer Patients
Enrolling by invitation NCT06078891 - Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease? Early Phase 1
Recruiting NCT05138848 - Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease N/A
Withdrawn NCT03149380 - Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior N/A
Recruiting NCT03653156 - China Cognition and Aging Study
Completed NCT03300726 - Synaptic Injury and Functional Connectivity in Alzheimer's Disease
Recruiting NCT05655195 - Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy N/A
Recruiting NCT05637801 - A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) N/A
Recruiting NCT03153371 - Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks